Statistics for Treatment Outcome of FOLFOX Versus Carboplatin–Paclitaxel as First Line Therapy for Advanced Squamous Cell Carcinoma of the Esophagus At TASH, Addis Ababa Ethiopia: A Comparative Retrospective Study.

Total visits

views
Treatment Outcome of FOLFOX Versus Carboplatin–Paclitaxel as First Line Therapy for Advanced Squamous Cell Carcinoma of the Esophagus At TASH, Addis Ababa Ethiopia: A Comparative Retrospective Study. 0

Total visits per month

views
January 2026 0
February 2026 0
March 2026 0
April 2026 0
May 2026 0
June 2026 0
July 2026 0